Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis

Journal of Hepatology

Volumn 57, Issue 3, 2012, Pages 663-674

  Nahon, Pierre ^a,b   Zucman Rossi, Jessica ^c,d,e  

^a UNIVERSITÉ PARIS 13   (France)

^b CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

Cirrhosis; Genetic variants; Liver cancer

Indexed keywords

ANTIVIRUS AGENT; CATALASE; CD24 ANTIGEN; CYTOCHROME P450 1A2; DNA; EPIDERMAL GROWTH FACTOR; GLUCURONOSYLTRANSFERASE 1A7; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; HFE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 28B; IRON; MANGANESE SUPEROXIDE DISMUTASE; MICRORNA 146A; MYELOPEROXIDASE; PROTEIN MDM2; PROTEIN P53; RANTES; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XRCC3 PROTEIN;

AMINO ACID SUBSTITUTION; ANTIVIRAL THERAPY; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; CELL CYCLE REGULATION; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA REPAIR; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNE RESPONSE; INFLAMMATION; IRON METABOLISM; LIVER CANCER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MEDICAL HISTORY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATIONAL RESEARCH;

CARCINOMA, HEPATOCELLULAR; DNA; DNA REPAIR; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INFLAMMATION; LIVER CIRRHOSIS; LIVER NEOPLASMS; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84865127217     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.02.035     Document Type: Review

References (112)

1. H.B. El-Serag Hepatocellular carcinoma N Engl J Med 365 2011 1118 1127
2. A. Sangiovanni, E. Del Ninno, P. Fasani, C. De Fazio, G. Ronchi, and R. Romeo Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance Gastroenterology 126 2004 1005 1014 (Pubitemid 38451172)
3. L. Benvegnu, M. Gios, S. Boccato, and A. Alberti Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications Gut 53 2004 744 749 (Pubitemid 38561455)
4. C. La Vecchia, F. Lucchini, S. Franceschi, E. Negri, and F. Levi Trends in mortality from primary liver cancer in Europe Eur J Cancer 36 2000 909 915 (Pubitemid 30214142)
5. H.B. El-Serag, and A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745 750 (Pubitemid 29114292)
6. S. Deuffic, T. Poynard, L. Buffat, and A.J. Valleron Trends in primary liver cancer Lancet 351 1998 214 215
7. L. Bolondi, S. Sofia, S. Siringo, S. Gaiani, A. Casali, and G. Zironi Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis Gut 48 2001 251 259 (Pubitemid 32141852)
8. S.N. Zaman, W.M. Melia, R.D. Johnson, B.C. Portmann, P.J. Johnson, and R. Williams Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients Lancet 1 1985 1357 1360 (Pubitemid 15060907)
9. F. Degos, C. Christidis, N. Ganne-Carrie, J.P. Farmachidi, C. Degott, and C. Guettier Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death Gut 47 2000 131 136 (Pubitemid 30430422)
10. J.F. Tsai, J.E. Jeng, M.S. Ho, W.Y. Chang, M.Y. Hsieh, and Z.Y. Lin Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study Br J Cancer 76 1997 968 974 (Pubitemid 27401953)
11. K. Tarao, Y. Rino, S. Ohkawa, A. Shimizu, S. Tamai, and K. Miyakawa Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis Cancer 86 1999 589 595 (Pubitemid 29379404)
12. L. Benvegnu, G. Fattovich, F. Noventa, F. Tremolada, L. Chemello, and A. Cecchetto Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study Cancer 74 1994 2442 2448 (Pubitemid 24320846)
13. H.B. El-Serag, T. Tran, and J.E. Everhart Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma Gastroenterology 126 2004 460 468 (Pubitemid 38182303)
14. G. N'Kontchou, J. Paries, M.T. Htar, N. Ganne-Carrie, L. Costentin, and V. Grando-Lemaire Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis Clin Gastroenterol Hepatol 4 2006 1062 1068 (Pubitemid 44137435)
15. E.J. Heathcote Prevention of hepatitis C virus-related hepatocellular carcinoma Gastroenterology 127 2004 S294 S302
16. Y.F. Liaw, J.J. Sung, W.C. Chow, G. Farrell, C.Z. Lee, and H. Yuen Lamivudine for patients with chronic hepatitis B and advanced liver disease N Engl J Med 351 2004 1521 1531
17. N. Ganne-Carrie, C. Chastang, F. Chapel, C. Munz, D. Pateron, and M. Sibony Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis Hepatology 23 1996 1112 1118 (Pubitemid 26137055)
18. R.F. Velazquez, M. Rodriguez, C.A. Navascues, A. Linares, R. Perez, and N.G. Sotorrios Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis Hepatology 37 2003 520 527 (Pubitemid 36258772)
19. J.P. Ioannidis, E.E. Ntzani, T.A. Trikalinos, and D.G. Contopoulos-Ioannidis Replication validity of genetic association studies Nat Genet 29 2001 306 309 (Pubitemid 33096456)
20. L.M. Dong, J.D. Potter, E. White, C.M. Ulrich, L.R. Cardon, and U. Peters Genetic susceptibility to cancer: the role of polymorphisms in candidate genes JAMA 299 2008 2423 2436 (Pubitemid 351749241)
21. B.K. Abu Dayyeh, M. Yang, B.C. Fuchs, D.L. Karl, S. Yamada, and J.J. Sninsky A functional polymorphism in the epidermal growth factor gene is associated with risk for hepatocellular carcinoma Gastroenterology 141 2011 141 149
22. F. Charni, A. Sutton, P. Rufat, C. Laguillier, A. Mansouri, and R. Moreau Chemokine RANTES promoter dimorphisms and hepatocellular carcinoma occurrence in patients with alcoholic or hepatitis C virus-related cirrhosis Cancer Epidemiol Biomarkers Prev 20 2011 1439 1446
23. R.J. Clifford, J. Zhang, D.M. Meerzaman, M.S. Lyu, Y. Hu, and C.M. Cultraro Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma Hepatology 52 2010 2034 2043
24. N. Dharel, N. Kato, R. Muroyama, M. Moriyama, R.X. Shao, and T. Kawabe MDM2 promoter SNP309 is associated with the risk of hepatocellular carcinoma in patients with chronic hepatitis C Clin Cancer Res 12 2006 4867 4871 (Pubitemid 44338572)
25. C. Fabris, E. Falleti, A. Cussigh, D. Bitetto, E. Fontanini, and S. Bignulin IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC J Hepatol 54 2011 716 722
26. E. Falleti, C. Fabris, P. Toniutto, E. Fontanini, A. Cussigh, and D. Bitetto Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end-stage liver disease Oncology 77 2009 304 313
27. Y. Gao, Y. He, J. Ding, K. Wu, B. Hu, and Y. Liu An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3' untranslated region confers risk for hepatocellular carcinoma Carcinogenesis 30 2009 2064 2069
28. Y. He, H. Zhang, J. Yin, J. Xie, X. Tan, and S. Liu IkappaBalpha gene promoter polymorphisms are associated with hepatocarcinogenesis in patients infected with hepatitis B virus genotype C Carcinogenesis 30 2009 1916 1922
29. T. Imaizumi, Y. Higaki, M. Hara, T. Sakamoto, M. Horita, and T. Mizuta Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population Carcinogenesis 30 2009 1729 1734
30. F. Jin, L.S. Qu, and X.Z. Shen Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis J Exp Clin Cancer Res 29 2010 18
31. F. Jin, W.J. Xiong, J.C. Jing, Z. Feng, L.S. Qu, and X.Z. Shen Evaluation of the association studies of single nucleotide polymorphisms and hepatocellular carcinoma: a systematic review J Cancer Res Clin Oncol 137 2011 1095 1104
32. N. Kato, G. Ji, Y. Wang, M. Baba, Y. Hoshida, and M. Otsuka Large-scale search of single nucleotide polymorphisms for hepatocellular carcinoma susceptibility genes in patients with hepatitis C Hepatology 42 2005 846 853 (Pubitemid 41401122)
33. V. Kumar, N. Kato, Y. Urabe, A. Takahashi, R. Muroyama, and N. Hosono Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma Nat Genet 43 2011 455 458
34. D. Li, L. Zheng, L. Jin, Y. Zhou, H. Li, and J. Fu CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection Hepatology 50 2009 735 742
35. X.D. Long, Y. Ma, Y. Qu de, Y.G. Liu, Z.Q. Huang, and Y.Z. Huang The polymorphism of XRCC3 codon 241 and AFB1-related hepatocellular carcinoma in Guangxi population, China Ann Epidemiol 18 2008 572 578 (Pubitemid 351802260)
36. X.D. Long, Y. Ma, Y.F. Zhou, A.M. Ma, and G.H. Fu Polymorphism in xeroderma pigmentosum complementation group C codon 939 and aflatoxin B1-related hepatocellular carcinoma in the Guangxi population Hepatology 52 2010 1301 1309
37. K. Migita, S. Miyazoe, Y. Maeda, M. Daikoku, S. Abiru, and T. Ueki Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection-association between TGF-beta1 polymorphisms and hepatocellular carcinoma J Hepatol 42 2005 505 510 (Pubitemid 40342929)
38. P. Nahon, A. Sutton, P. Rufat, M. Ziol, H. Akouche, and C. Laguillier Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis Hepatology 50 2009 1484 1493
39. P. Nahon, A. Sutton, P. Rufat, M. Ziol, G. Thabut, and P.O. Schischmanoff Liver iron, HFE gene mutations, and hepatocellular carcinoma occurrence in patients with cirrhosis Gastroenterology 134 2008 102 110 (Pubitemid 350309327)
40. K.K. Tanabe, A. Lemoine, D.M. Finkelstein, H. Kawasaki, T. Fujii, and R.T. Chung Epidermal growth factor gene functional polymorphism and the risk of hepatocellular carcinoma in patients with cirrhosis JAMA 299 2008 53 60
41. C.S. Tseng, K.S. Tang, H.W. Lo, C.G. Ker, H.C. Teng, and C.S. Huang UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age Am J Gastroenterol 100 2005 1758 1763
42. L. Valenti, M. Rumi, E. Galmozzi, A. Aghemo, B. Del Menico, and S. De Nicola Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C Hepatology 53 2011 791 799
43. B. Wang, G. Huang, D. Wang, A. Li, Z. Xu, and R. Dong Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis J Hepatol 53 2011 508 518
44. Y. Wang, N. Kato, Y. Hoshida, M. Otsuka, H. Taniguchi, and M. Moriyama UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma in Japanese patients with hepatitis C virus infection Clin Cancer Res 10 2004 2441 2446 (Pubitemid 38445704)
45. Y. Wang, N. Kato, Y. Hoshida, H. Yoshida, H. Taniguchi, and T. Goto Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection Hepatology 37 2003 65 71 (Pubitemid 36042146)
46. Y. Wei, F. Liu, B. Li, X. Chen, Y. Ma, and L. Yan Polymorphisms of tumor necrosis factor-alpha and hepatocellular carcinoma risk: a huge systematic review and meta-analysis Dig Dis Sci 2011
47. T. Xu, Y. Zhu, Q.K. Wei, Y. Yuan, F. Zhou, and Y.Y. Ge A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma Carcinogenesis 29 2008 2126 2131
48. Y.J. Yoon, H.Y. Chang, S.H. Ahn, J.K. Kim, Y.K. Park, and D.R. Kang MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection Carcinogenesis 29 2008 1192 1196 (Pubitemid 351964880)
49. J.M. Yuan, S.C. Lu, D. Van Den Berg, S. Govindarajan, Z.Q. Zhang, and J.M. Mato Genetic polymorphisms in the methylenetetrahydrofolate reductase and thymidylate synthase genes and risk of hepatocellular carcinoma Hepatology 46 2007 749 758 (Pubitemid 47436121)
50. Y. Zhai, G. Zhou, G. Deng, W. Xie, X. Dong, and X. Zhang Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers Gastroenterology 130 2006 2001 2009 (Pubitemid 43816947)
51. H. Zhang, Y. Zhai, Z. Hu, C. Wu, J. Qian, and W. Jia Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers Nat Genet 42 2010 755 758
52. P. Nahon, A. Sutton, P. Rufat, N. Charnaux, A. Mansouri, and R. Moreau A variant in myeloperoxidase promoter hastens the emergence of hepatocellular carcinoma in patients with HCV-related cirrhosis J Hepatol 2011
53. E. Trepo, E. Guyot, N. Ganne-Carrie, D. Degre, T. Gustot, and D. Franchimont PNPLA3 (rs738409 C>G) is a common risk variant associated with hepatocellular carcinoma in alcoholic cirrhosis Hepatology 2011
54. D. Miki, H. Ochi, C.N. Hayes, H. Abe, T. Yoshima, and H. Aikata Variation in the DEPDC5 locus is associated with progression to hepatocellular carcinoma in chronic hepatitis C virus carriers Nat Genet 43 2011 797 800
55. Y. Yang, C. Luo, R. Feng, and S. Bi The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis J Cancer Res Clin Oncol 137 2011 947 952
56. Y.G. Wei, F. Liu, B. Li, X. Chen, Y. Ma, and L.N. Yan Interleukin-10 gene polymorphisms and hepatocellular carcinoma susceptibility: a meta-analysis World J Gastroenterol 17 2011 3941 3947
57. L. Sheng, and Y. Shui Clusters of differentiation 24 polymorphism and hepatocellular carcinoma Hepatology 54 2011 2274 2275
58. X.J. Yu, F. Fang, C.L. Tang, L. Yao, L. Yu, and L. Yu DbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma Hum Mutat 32 2011 E2308 E2316
59. E.H. Sarsour, M.G. Kumar, L. Chaudhuri, A.L. Kalen, and P.C. Goswami Redox control of the cell cycle in health and disease Antioxid Redox Signal 11 2009 2985 3011
60. J.Y. Choi, M.L. Neuhouser, M.J. Barnett, C.C. Hong, A.R. Kristal, and M.D. Thornquist Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort Carcinogenesis 29 2008 964 970 (Pubitemid 351982241)
61. Y.J. Hu, and A.M. Diamond Role of glutathione peroxidase 1 in breast cancer: loss of heterozygosity and allelic differences in the response to selenium Cancer Res 63 2003 3347 3351 (Pubitemid 36735893)
62. W.F. Reynolds, E. Chang, D. Douer, E.D. Ball, and V. Kanda An allelic association implicates myeloperoxidase in the etiology of acute promyelocytic leukemia Blood 90 1997 2730 2737 (Pubitemid 27413483)
63. A. Sutton, P. Nahon, D. Pessayre, P. Rufat, A. Poire, and M. Ziol Genetic polymorphisms in antioxidant enzymes modulate hepatic iron accumulation and hepatocellular carcinoma development in patients with alcohol-induced cirrhosis Cancer Res 66 2006 2844 2852
64. D.L. White, D. Li, Z. Nurgalieva, and H.B. El-Serag Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis Am J Epidemiol 167 2008 377 389 (Pubitemid 351264139)
65. K.E. Brown, E.M. Brunt, and J.W. Heinecke Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver Am J Pathol 159 2001 2081 2088 (Pubitemid 33104262)
66. S.J. Klebanoff Myeloperoxidase: friend and foe J Leukoc Biol 77 2005 598 625 (Pubitemid 40628741)
67. D.C. Wallace Mitochondrial diseases in man and mouse Science 283 1999 1482 1488
68. G. Bjelakovic, D. Nikolova, L.L. Gluud, R.G. Simonetti, and C. Gluud Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis JAMA 297 2007 842 857 (Pubitemid 46333949)
69. Y. Deugnier, and B. Turlin Pathology of hepatic iron overload World J Gastroenterol 13 2007 4755 4760 (Pubitemid 47455566)
70. M. Elmberg, R. Hultcrantz, A. Ekbom, L. Brandt, S. Olsson, and R. Olsson Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives Gastroenterology 125 2003 1733 1741 (Pubitemid 37500438)
71. S. Fargion, M.A. Stazi, A.L. Fracanzani, M. Mattioli, M. Sampietro, and D. Tavazzi Mutations in the HFE gene and their interaction with exogenous risk factors in hepatocellular carcinoma Blood Cells Mol Dis 27 2001 505 511 (Pubitemid 32547851)
72. C. Hellerbrand, A. Poppl, A. Hartmann, J. Scholmerich, and G. Lock HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence Clin Gastroenterol Hepatol 1 2003 279 284 (Pubitemid 37254455)
73. V. Boige, L. Castera, N. de Roux, N. Ganne-Carrie, B. Ducot, and G. Pelletier Lack of association between HFE gene mutations and hepatocellular carcinoma in patients with cirrhosis Gut 52 2003 1178 1181 (Pubitemid 36877432)
74. E. Cauza, M. Peck-Radosavljevic, H. Ulrich-Pur, C. Datz, M. Gschwantler, and M. Schoniger-Hekele Mutations of the HFE gene in patients with hepatocellular carcinoma Am J Gastroenterol 98 2003 442 447 (Pubitemid 36232397)
75. E. Lauret, M. Rodriguez, S. Gonzalez, A. Linares, A. Lopez-Vazquez, and J. Martinez-Borra HFE gene mutations in alcoholic and virus-related cirrhotic patients with hepatocellular carcinoma Am J Gastroenterol 97 2002 1016 1021 (Pubitemid 34408263)
76. R.W. Lambrecht, R.K. Sterling, D. Naishadham, A.M. Stoddard, T. Rogers, and C. Morishima Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C Gastroenterology 140 2011 1490 1500 [e1493]
77. J. Kato, K. Miyanishi, M. Kobune, T. Nakamura, K. Takada, and R. Takimoto Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C J Gastroenterol 42 2007 830 836 (Pubitemid 47617461)
78. H.B. El-Serag, and K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557 2576 (Pubitemid 46890874)
79. C. Berasain, J. Castillo, M.J. Perugorria, M.U. Latasa, J. Prieto, and M.A. Avila Inflammation and liver cancer: new molecular links Ann N Y Acad Sci 1155 2009 206 221
80. J. Boisvert, E.J. Kunkel, J.J. Campbell, E.B. Keeffe, E.C. Butcher, and H.B. Greenberg Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes J Hepatol 38 2003 67 75 (Pubitemid 36078526)
81. K.F. Yoong, S.C. Afford, R. Jones, P. Aujla, S. Qin, and K. Price Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma Hepatology 30 1999 100 111 (Pubitemid 29300575)
82. K. Promrat, D.H. McDermott, C.M. Gonzalez, D.E. Kleiner, D.E. Koziol, and M. Lessie Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C Gastroenterology 124 2003 352 360 (Pubitemid 36169252)
83. P. Nahon, A. Sutton, P. Rufat, C. Faisant, C. Simon, and N. Barget Lack of association of some chemokine system polymorphisms with the risks of death and hepatocellular carcinoma occurrence in patients with alcoholic cirrhosis: a prospective study Eur J Gastroenterol Hepatol 19 2007 425 431 (Pubitemid 46596697)
84. P. Nahon, A. Sutton, P. Rufat, C. Simon, J.C. Trinchet, and L. Gattegno Chemokine system polymorphisms, survival and hepatocellular carcinoma occurrence in patients with hepatitis C virus-related cirrhosis World J Gastroenterol 14 2008 713 719 (Pubitemid 351325053)
85. F. Staib, S.P. Hussain, L.J. Hofseth, X.W. Wang, and C.C. Harris TP53 and liver carcinogenesis Hum Mutat 21 2003 201 216 (Pubitemid 36292963)
86. G.L. Bond, W. Hu, E.E. Bond, H. Robins, S.G. Lutzker, and N.C. Arva A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 119 2004 591 602 (Pubitemid 39535748)
87. J.P. Ioannidis, P. Boffetta, J. Little, T.R. O'Brien, A.G. Uitterlinden, and P. Vineis Assessment of cumulative evidence on genetic associations: interim guidelines Int J Epidemiol 37 2008 120 132 (Pubitemid 351228620)
88. S. Wacholder, S. Chanock, M. Garcia-Closas, L. El Ghormli, and N. Rothman Assessing the probability that a positive report is false: an approach for molecular epidemiology studies J Natl Cancer Inst 96 2004 434 442 (Pubitemid 38443646)
89. P. Blanc, H. Etienne, M. Daujat, I. Fabre, F. Zindy, and J. Domergue Mitotic responsiveness of cultured adult human hepatocytes to epidermal growth factor, transforming growth factor alpha, and human serum Gastroenterology 102 1992 1340 1350
90. E. Schiffer, C. Housset, W. Cacheux, D. Wendum, C. Desbois-Mouthon, and C. Rey Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis Hepatology 41 2005 307 314 (Pubitemid 40165374)
91. M. Lanuti, G. Liu, J.M. Goodwin, R. Zhai, B.C. Fuchs, and K. Asomaning A functional epidermal growth factor (EGF) polymorphism, EGF serum levels, and esophageal adenocarcinoma risk and outcome Clin Cancer Res 14 2008 3216 3222
92. M. Shahbazi, V. Pravica, N. Nasreen, H. Fakhoury, A.A. Fryer, and R.C. Strange Association between functional polymorphism in EGF gene and malignant melanoma Lancet 359 2002 397 401 (Pubitemid 34158948)
93. R.S. Pillai MicroRNA function: multiple mechanisms for a tiny RNA? RNA 11 2005 1753 1761 (Pubitemid 41720024)
94. E.A. Wiemer The role of microRNAs in cancer: no small matter Eur J Cancer 43 2007 1529 1544 (Pubitemid 46901017)
95. S. Huang, and X. He The role of microRNAs in liver cancer progression Br J Cancer 104 2011 235 240
96. K. Chen, F. Song, G.A. Calin, Q. Wei, X. Hao, and W. Zhang Polymorphisms in microRNA targets: a gold mine for molecular epidemiology Carcinogenesis 29 2008 1306 1311
97. K. Jazdzewski, E.L. Murray, K. Franssila, B. Jarzab, D.R. Schoenberg, and A. de la Chapelle Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Proc Natl Acad Sci U S A 105 2008 7269 7274 (Pubitemid 351754467)
98. K. Chen, and N. Rajewsky Natural selection on human microRNA binding sites inferred from SNP data Nat Genet 38 2006 1452 1456 (Pubitemid 44837570)
99. D. Landi, F. Gemignani, R. Barale, and S. Landi A catalog of polymorphisms falling in microRNA-binding regions of cancer genes DNA Cell Biol 27 2008 35 43
100. T.H. Karlsen, E. Melum, and A. Franke The utility of genome-wide association studies in hepatology Hepatology 51 2010 1833 1842
101. Z.K. Stadler, D.J. Gallagher, P. Thom, and K. Offit Genome-wide association studies of cancer: principles and potential utility Oncology (Williston Park) 24 2010 629 637
102. A. Balagopal, D.L. Thomas, and C.L. Thio IL28B and the control of hepatitis C virus infection Gastroenterology 139 2010 1865 1876
103. S. Romeo, J. Kozlitina, C. Xing, A. Pertsemlidis, D. Cox, and L.A. Pennacchio Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
104. C. Tian, R.P. Stokowski, D. Kershenobich, D.G. Ballinger, and D.A. Hinds Variant in PNPLA3 is associated with alcoholic liver disease Nat Genet 42 2010 21 23
105. X. Yuan, D. Waterworth, J.R. Perry, N. Lim, K. Song, and J.C. Chambers Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes Am J Hum Genet 83 2008 520 528
106. S.G. Corradini, M.A. Burza, A. Molinaro, and S. Romeo Patatin-like phospholipase domain containing 3 sequence variant and hepatocellular carcinoma Hepatology 53 2011 1776 [author reply 1777]
107. H.D. Nischalke, C. Berger, C. Luda, T. Berg, T. Muller, and F. Grunhage The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis PLoS ONE 6 2011 e27087
108. A. Bagchi, and A.A. Mills The quest for the 1p36 tumor suppressor Cancer Res 68 2008 2551 2556 (Pubitemid 351556249)
109. S. Bauer, V. Groh, J. Wu, A. Steinle, J.H. Phillips, and L.L. Lanier Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA Science 285 1999 727 729
110. T.J. Seng, K. Ichimura, L. Liu, O. Tingby, D.M. Pearson, and V.P. Collins Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis Genes Chromosomes Cancer 43 2005 181 193 (Pubitemid 40570738)
111. J.P. Ioannidis, P. Castaldi, and E. Evangelou A compendium of genome-wide associations for cancer: critical synopsis and reappraisal J Natl Cancer Inst 102 2010 846 858
112. S. Wacholder, P. Hartge, R. Prentice, M. Garcia-Closas, H.S. Feigelson, and W.R. Diver Performance of common genetic variants in breast-cancer risk models N Engl J Med 362 2010 986 993